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Speakers: Volker M.Arlt (Institute of Cancer Research, UK), Frederick A.Beland (National 
Center for Toxicological Research; USA), Karen Brown (University of Leicester, UK), 
Marcus Cooke (University of Leicester, UK), Andrew Collins (University of Oslo, Norway), 
Silvio De Flora (University of Genoa, Italy), Eugenia Dogliotti (Istituto Superiore di Sanità, 
Italy), Bernd Epe (University of Mainz, Germany), Peter B.Farmer (University of Leicester, 
UK), Hansruedi Glatt (German Institute of Human Nutrition, Germany), Roger W.Godschalk 
(University of Maastricht, The Netherlands), Stephen S.Hecht (University of Minnesota, 
USA), Hanna L.Karlsson (Karolinska Institute, Sweden), Micheline Kirsch-Volders (Vrije 
Universiteit Brussels, Belgium), Soterios Kyrtopoulos (National Hellenic Research 
Foundation, Greece), Steffen Loft (University of Copenhagen, Denmark), Ryszard Olinski 
(Nicolaus Copernicus University, Poland), David H.Phillips (Institute of Cancer Research, 
UK), Miriam C.Poirier (National Cancer Institute, USA), Roel Schins (University of 
Düsseldorf, Germany), Heinz H.Schmeiser (German Cancer Research Center, Germany), 
Tanja Schwerdtle (University of Münster, Germany), Albrecht Seidel (Biochemical Institute 
for Environmental Carcinogens, Germany), Günter Speit (University of Ulm, Germany), 
Marie Stiborova (Charles University Prague, Czech Republic), Helga Stopper (University of 
Würzburg, Germany), Jan Topinka (Institute of Experimental Medicine AS, Czech Republic), 
Frederik-Jan van Schooten (University of Maastricht, The Netherlands), Roel Vermeulen 
(Utrecht University, The Netherlands). 
 
Environmental exposures are a major concern for human cancer. However, the precise 
contribution of specific risk factors and their interactions, both with each other and with 
genotype, continue to be difficult to elucidate. The exposome is the comprehensive 
characterisation of an individual’s lifetime exposure history (Wild [2009] Mutagenesis 24: 
117-125). Unravelling complex environmental and genetic aetiologies in order to plan 
effective public health interventions demands that both environmental exposures and genetic 
variations are reliably measured. The development, validation and application of biomarkers 
of exposure are manifestly critical to the future of cancer epidemiology. The aim of this 
workshop at the University of Münster was to discuss the current status of exposure 
biomarkers in cancer molecular epidemiology as well as new findings achieved by applying 
the methods to studies of mechanisms of human cancer. Day one focused on biomarkers of 
exposure (i.e carcinogen DNA adducts), effect and susceptibility to gain greater 
understanding of environmental cancer risks and their modulation. Day two focused on the 
role of oxidative stress and DNA damage in human carcinogenesis including methodologies 
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used for the measurement of oxidatively induced DNA lesions in human cells or tissues and 
the possible use of these lesions as cancer biomarkers.     
 
The United Kingdom Environmental Mutagen Society (UKEMS), the Dutch Environmental 
Mutagen Society (Dutch EMS) and the German Environmental Mutagen Society (GUM) 
sponsored a two-day workshop (28-29 March 2011) at the University of Münster in Münster, 
Germany, on biomarkers of exposure and oxidative damage to DNA to gain a greater 
understanding of environmental cancer risks and their modulation [1,2]. After nearly 5 years 
this is the 2nd international workshop on this topic after the first one was held September 2006 
in Heidelberg, Germany, jointly sponsored by the Environmental Cancer Risk, Nutrition and 
Individual Susceptibility (ECNIS) EU Network of Excellence and the GUM [3]. The 
workshop in Münster provided a unique forum bringing together scientists working in this 
research area from Europe, United States, South America and Asia. More than 180 
researchers from 20 countries took part. Within the workshop 29 lectures were given and 
nearly 80 posters presented.  
 The opening keynote lecture entitled ‘Carcinogen biomarkers for investigating tobacco 
and cancer’ was given by Stephen Hecht (University of Minnesota, USA). Among lifestyle 
factors definitely related to cancer, tobacco use arguably entails the largest human exposure to 
diverse chemical carcinogens including tobacco-specific nitrosamines (e.g. 4-
(methylnitrosamino)-1-(3-pyridyl)-1-butanone [NNK], 4-(methylnitrosamino)-1-(3-pyridyl)-
1-butanol [NNAL]), aldehydes, and polycyclic aromatic hydrocarbons (PAHs) [4]. People 
exposed to secondhand tobacco smoke (SHS) inhale the lung carcinogen NNK which is 
metabolised to NNAL which can be measured in urine and has emerged as an excellent 
biomarker of NNK uptake. Urine samples from 79 children exposed to SHS were analysed for 
total NNAL [5]. The study showed that children were nearly all exposed to NNK due mainly 
to exposure to SHS from adult smokers in their homes implicating that adult smokers should 
adopt restrictions to protect their children from SHS. Another validated biomarker of PAH 
exposure is r-1,t-2,3,c-4-tetrahydroxy-1,2,3,4-tetrahydrophenanthrene (PheT) and urinary 
levels of PheT and NNAL in relation to lung cancer development in cigarette smokers were 
examined in the Shanghai Cohort Study [6]. This case-control study nested within the cohort 
included 475 lung cancer patients (cases) who smoked cigarettes at recruitment and 475 
current smokers (controls). Urinary levels of PheT and NNAL were significantly higher for 
cases than controls after adjustment for smoking intensity and duration confirming them as 
risk biomarkers for lung cancer in smokers. Albrecht Seidel (Biochemical Institute for 
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Environmental Carcinogens, Germany) reported that the determination of urinary excreted 
PAH metabolites (e.g. of pyrene and phenanthrene) can be used in human biomonitoring at 
the workplace [7,8]. The occupational settings included employees of a manufacturer of 
graphite electrodes, employees of a coking plant and employees feeding converters during 
steel production. Overall, phenanthrene diols appeared to be sensitive biomarkers of PAH 
exposure. The various types of phenanthrene metabolites (phenols, diols and phenanthrene 
tetrol) could probably be used in future studies for phenotyping of individuals to determine 
their possible susceptibility to develop cancer upon exposure to PAH mixtures.  
 Silvio De Flora (University of Genoa, Italy) delivered a talk on ‘Induction of 
biomarker and tumours by cigarette smoke (CS), and their chemoprevention’. 
Chemopreventive agents of natural or pharmacological origin, such as N-acetyl-L-cysteine 
(NAC), phenethyl isothiocyanate (PEITC), and budesonide, have been shown to modulate 
CS-altered end-points (e.g. DNA adduct formation, oxidative damage to DNA, gene 
expression) [9]. However, only recently a suitable animal model for evaluating CS 
carcinogenicity was developed. This mouse model was successfully used to demonstrate the 
ability of NAC, PEITC and budesonide to prevent smoke-induced lung cancer, according to 
protocols mimicking the situation either in current smokers or in ex-smokers [10]. NAC and 
ascorbic acid were also successful to prevent lung cancer induced by mainstream CS after 
birth when they were administered during prenatal life. Transplacental CS carcinogenicity and 
its modulation were also investigated [11]. Miriam Poirier (National Cancer Institute, USA) 
evaluated the chemopreventive potential of chlorophyllin (CHL) [12] in a mouse model of 
esophageal cancer in cancer-susceptible mice (i.e. Xpa−/−, Tp53+/− mice) fed with 
benzo[a]pyrene (BaP) in the diet. Exceedingly high esophageal cancer rates in Linxian, China, 
have been associated with the ingestion and inhalation of PAHs in the ambient environment 
[13]. Wild-type (WT) mice, which are repair proficient, fed with 100 ppm BaP typically had 
less DNA damage than repair-deficient Xpa(−/−)Tp53(+/− ) mice in esophagi, livers and 
lungs. Mice fed with 100 ppm BaP/0.3% CHL had reduced BaP-DNA adduct levels in the 
liver, but no change in other organs, compared to mice fed with BaP alone, indicating that, 
contrary to expectations, CHL did not always decrease BaP-induced DNA damage in vivo. 
‘What BaP does to cells, and what cells do to BaP’ was discussed by David Phillips (Institute 
of Cancer Research, UK). Discovered and identified more than 75 years ago, the 
environmental carcinogen BaP is still widely studied and has become a standard test agent for 
exploring the metabolic capacity of biological systems and the responses of cells or tissues in 
vitro or in vivo to external genotoxic insult. Recent studies demonstrated that cytochrome 
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P450s (CYPs), involved in BaP metabolism, seems to be more important for detoxication of 
BaP in vivo despite being important for its bioactivation in vitro [14]. DNA adduct formation 
by BaP, but not by its reactive metabolite BaP-diolepoxide (BPDE), appears to be p53- 
dependent, suggesting that loss of p53 affects metabolic activation [15]. Meanwhile in vivo 
studies have shown that BaP forms DNA adducts with equal measure in both target and non-
target tissues, while gene expression changes are organ specific. 
Frederik-Jan van Schooten (University of Maastricht, The Netherlands) discussed that 
low oxygen concentrations in chronic obstructive pulmonary disease (COPD) [16] affected 
lung tissues may be involved in the enhanced lung cancer risk. He showed that hypoxia-
related activation of hypoxia-inducible factor 1 (HIF1α) amplifies a BaP-induced mutagenic 
phenotype [17]. Several processes may in part be responsible for this phenotype: (i) changes 
in BaP metabolism; (ii) transmembrane transport of BaP or its metabolites; and (iii) the repair 
capacity of the subsequent DNA damage. For example, cells in which HIF1α is dysregulated 
(VHL mutants) had an approximately 10-fold decrease in the ability to repair BaP-DNA 
adducts. Enhanced cancer risks in COPD patients may be a result of inflammatory-related 
DNA damaging effects and oxygen restriction leading to hypoxia. Micheline Kirsch-Volders 
(Vrije Universiteit Brussels, Belgium) reported that birth can be seen as a ‘hyperoxic’ 
challenge since newborns leave an intra-uterine ‘hypoxic’ environment to enter a ‘normoxic’ 
environment. The in vitro genetic susceptibility for hydrogen peroxide in peripheral blood 
mononuclear cells (PBMC) of mother-fullterm newborn and mother-preterm newborn pairs 
was investigated using the comet and micronucleus (MN) [18] assay, taking into account 
some relevant genotypes, e.g. in DNA repair [19,20]. Overall, fullterm newborns were less 
sensitive to the in vitro induced oxidative stress as compared to adults. Mothers accumulated 
higher background frequencies of micronuclei as compared to their fullterm newborn 
daughters, confirming the age factor. Newborns carrying the variant XRCC3241 genotype were 
at higher risk of MN by oxidative stress. Günter Speit (University of Ulm) critically discussed 
‘The MN test as a biomarker for cancer risk and exposure to genotoxic agents’ [21]. The 
major questions addressed were: What is the origin of micronuclei? Is the MN frequency a 
predictor of cancer risk? Is the cytokinesis-block micronucleus test (CBMNT) a sensitive test 
for human biomonitoring of mutagen-exposed populations? Conclusions included that the 
CBMNT is designed to detect micronuclei in lymphocytes after division in vitro. Micronuclei 
in vivo will not significantly contribute to the micronuclei frequency in binuclear cells. Cancer 
risks are associated with higher baseline MN frequencies. It has not been shown that cancer 
risks are associated with environmental exposure to mutagens. MN can be formed before 
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cytochalasin-B is added and these cells will usually not appear as binucleated cells with 
micronuclei. The standard protocol of the CBMNT used in biomonitoring is not sensitive for 
the detection of cells damaged in vivo. 
 Soterios Kyrtopoulos delivered a talk on ‘Progress in the use of traditional and omics-
based biomarkers of exposure in population studies’. Despite extensive development of 
different technologies of biomarkers of carcinogenic exposure, in view of the growing need 
for larger population-based studies assay sensitivity and throughput have become limiting 
factors. Progress has been made in developing sensitive ELISA-type immunoassays to detect 
DNA adducts of environmental interest such as O6-methylguanine and BPDE-type adducts. 
The assay uses anti-adduct antibodies to bind selectively to a solid surface adduct-containing 
DNA fragments, followed by quantitation of the latter with anti-DNA antisera [22]. Assays 
have been used for the analysis of more than 1,000 DNA samples from maternal and cord 
blood in the context of the NewGeneris project [23] confirming their applicability in 
population studies. Assays can be extended to other DNA adducts, and have the potential for 
automation and multiplexing. 
 Several presentations focused on the 32P-postlabelling method to detect DNA adducts. 
Heinz Schmeiser (German Cancer Research Center, Germany) discussed ‘DNA adducts 
formed by arachidonic acid metabolites’. Arachidonic acid derived mediators, the eicosanoids, 
play a fundamental role in physiological and pathological processes involved in inflammatory 
responses. Reactive metabolites include LTA4 (5,6-epoxy-7,9,11,14-eicosatetraenoic acid) 
and four cis-epoxyeicosatrienoic acids (14,15-, 11,12-, 8,9- and 5,6-EET). When the human 
monocytic cell line Mono Mac 6 was stimulated with arachidonic acid and calcium ionophore 
LTA4-DNA adducts were detected by 32P-postlabelling, the major ones being derived from 
deoxyguanosine [24]. EETs were also capable of forming adducts, primarily with 
deoxyguanosine; highest DNA binding was found with 11,12-EET. The method seems to be 
suitable to study the relationship between inflammation and the onset of cancer. Jan Topinka 
(Institute of Experimental Medicine AS CR, Czech Republic) evaluated the genotoxicity of 
complex mixtures of air pollutants (e.g. PAHs and their derivatives) bound to PM2.5 ambient 
air dust particles collected in various localities of the Czech Republic which differed in the 
extent and sources of air pollution [25]. Organic extracts were prepared and DNA adduct 
formation was assessed by 32P-postlabelling and related to the carcinogenic PAHs (c-PAHs) 
content. The study confirmed that c-PAHs and particularly BaP are mostly responsible for the 
genotoxicity of PM2.5. Gene expression analysis in mammalian cells revealed that multiple 
transcripts/genes were significantly correlated with BaP content in organic extracts and DNA 
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adduct levels. Marie Stiborova (Charles University Prague, Czech Republic) reported on the 
‘Detection of DNA adducts formed by environmental pollutants by 32P-postlabelling’ 
including the azo dye 1-phenylazo-2-naphthol (Sudan I) [26], the nitro-aromatics 3-
nitrobenzanthrone (3-NBA) and 2-nitroanisole, and aromatic amines such as o-anisidine [27]. 
Recent studies on the air pollutant 3-NBA showed that it induces the cytosolic nitroreductase 
NAD(P)H:quinone oxidoreductase (NQO1) in liver, kidney and lungs of rats treated by intra-
tracheal instillation, thereby enhancing its own genotoxic and carcinogenic potential [28]. In 
contrast, the 3-NBA isomer 2-nitrobenzanthrone (2-NBA) was not metabolised by NQO1; no 
2-NBA-derived DNA adducts were detectable [29]. Molecular docking of 2-NBA and 3-NBA 
to the active site of NQO1 showed similar binding affinities; however, the binding orientation 
of 2-NBA does not favour the reduction of the nitro group. These results suggest that 2-NBA 
possesses a lower risk to humans than 3-NBA. The role of CYP enzymes in the detoxication 
and activation of aristolochic acid (AA) was discussed by Volker Arlt (Institute of Cancer 
Research, UK). AAI, the main ingredient of Aristolochia species, represents one of the few 
carcinogens of which the relationship between DNA adduct formation and human cancer has 
been defined [30]. The predominant DNA adduct formed in vivo is 7-(deoxyadenosin-N6-
yl)aristolactam I, which is a premutagenic lesion leading to AT to TA transversions in the 
TP53 gene  [31]. The metabolism of AAI was investigated using the HRN (Hepatic 
Cytochrome P450 Reductase Null) mouse model in which the unique electron donor to CYPs 
is deleted specifically in the liver, resulting in the loss of essentially all hepatic CYP function 
[32]. Hepatic CYPs demethylated AAI in vitro to the detoxication metabolite 8-
hydroxyaristolochic acid I (aristolochic acid Ia), indicating that less AAI is distributed to 
extra-hepatic organs in WT mice. Indeed, AAI-DNA adduct levels (measured by 32P-
postlabelling) in organs of HRN mice, having low hepatic AAI demethylation capacity, were 
increased significantly. AAI demethylation was attributable mainly to mouse CYP1A1 and 
CYP1A2, indicating that AAI activation and detoxication by CYPs in mice are mainly 
dictated by its binding affinity to CYP1A1 and CYP1A2, by their turnover and by the balance 
between the ability of CYP1A enzymes to oxidize and reduce AAI.  
 Frederick Beland (National Center for Toxicological Research, USA) and Hansruedi 
Glatt (German Institute of Human Nutrition, Germany) both discussed the genotoxic risk from 
dietary exposure. Beland reported that acrylamide [33,34] and furan have been detected as 
contaminants in many common foods cooked at high temperatures, and are carcinogenic in 
laboratory animals. Two-year chronic bioassays were conducted in F344 rats with acrylamide 
and furan to provide dose-response data for tumour induction. In addition, mechanistic studies 
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were performed to characterise the conversion of acrylamide to glycidamide and furan to cis-
butene-1,4-diol in the carcinogenic process. Collectively, the data show that acrylamide is 
carcinogenic through a mechanism involving the formation of glycidamide; furan is also 
carcinogenic but the mechanism at the present time is uncertain. Glatt reported on ‘DNA 
adducts by food constituents in mouse models genetically modified in the sulfotransferase 
(SULT) status’. In vitro and in vivo models were developed for studying SULT-dependent 
genotoxicants. DNA adduct formation in SULT1A1/1A2-humanised mouse tissues was 
enhanced by compounds including 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) 
and 1-hydroxymethypyrene. The influence of the SULT1A1/1A2 transgene on adduct 
formation was different for the test compounds and differences could be rationalised on the 
basis of the administration route and physico-chemical properties of the administered 
compound and its metabolites. In another study, the origin of the main DNA adduct found in 
tissues of rats fed with raw broccoli could be related to the glucosinolate neoglucobrassicin 
[35,36]. 
 Roel Vermeulen (Utrecht University, The Netherlands) discussed ‘The use of 
intermediate endpoint biomarkers in cancer aetiology and risk assessment‘. Intermediate 
biomarkers directly or indirectly represent events on the continuum between exposure and 
disease. As such, they complement epidemiological studies that use cancer endpoints. In 
addition, intermediate biomarkers can provide initial clues about the carcinogenic potential of 
new exposures before cancer develops. Benzene was presented as an example [37,38] for 
which intermediate markers are more frequently being used in cancer risk assessment [39].  
 The second keynote lecture was given by Steffen Loft (University of Copenhagen, 
Denmark) on ‘Oxidative damage to DNA as biomarker of exposure to air pollution’. Air 
pollution is suspected of causing lung cancer [40] and traffic is one of the major sources of 
harmful airborne particles worldwide [41]. Air pollution is thought to exert health effects 
through oxidative stress which includes the formation of DNA damage [42]. Individual 
assessment of exposure to combustion-derived particulate matter may be improved by 
measuring biomarkers of oxidative damage to DNA in humans. For DNA lesions in 
leukocytes it is recommended to use methods such as the FPG- or hOGG1-modified comet 
assay, whereas for urinary detection of 8-oxo-7,8-dihydro-2’-deoxyguanosine (8-oxodG) 
chromatographic assays with specific detection by mass spectrometry or electrochemistry are 
preferred. Series of studies showed that exposure to traffic-related combustion particles 
increased DNA oxidation in leukocytes, whereas wood smoke particles appeared to have less 
effect. Exposure to combustion particles consistently increases the level of oxidatively 
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damaged DNA in humans supporting the use of measurements as biomarkers of biological 
effective dose. Peter Farmer (University of Leicester, UK) reported on ‘The role of oxidative 
DNA damage markers in molecular cancer epidemiology studies: 8-oxodG – is there an 
alternative?’ The most frequently used biomarker of DNA damage linked to oxidative stress is 
the amount of 8-oxodG present in DNA [43,44]. However, this lesion may be produced 
spuriously during DNA isolation and work-up procedures. Another approach to indicate 
exposure to reactive oxygen species (ROS) is the analysis of the DNA adduct with 
malondialdelyde, 3-(2’-deoxy-β-D-erythro-pentofuranosyl)pyrimido[1,2-α]purin-10(3H)-one 
(M1dG), as M1dG is not subject to artifactual formation [43,44]. An immunoslot blot 
procedure for determination of M1dG was developed and M1dG levels were influenced by 
exposure to air pollution and by dietary influences, suggesting its potential as an oxidative 
DNA damage biomarker. Another potential biomarker of oxidative stress may be 7-(2-
hydroxyethyl)guanine, a DNA adduct produced by ethylene oxide [45]. Marcus Cooke 
(University of Leicester, UK) discussed the measurement of 8-oxodG in urine [46] using both 
ELISA and chromatographic methods [47]. The European Standards Committee on Urinary 
(DNA) Lesion Analysis (ESCULA) [48] comprises over 30 laboratories from Europe, USA 
and Japan to address questions of lesion provenance and methodological variation, with a 
view to providing analyses that are highly applicable to large, population-based studies of 
genotoxic exposure and, with appropriate validation, to clinical studies.  
 Andrew Collins (University of Oslo, Norway) discussed ‘Antioxidant and non-
antioxidant effects of phytochemicals’. The comet assay has proved to be particularly useful 
as a human biomonitoring tool. The use of enzymes that convert oxidised bases to DNA 
breaks has made it possible to measure oxidative damage specifically, and to assess 
antioxidant protection against this damage [49]. Although it has been possible to detect the 
effects of natural antioxidants (e.g. vitamin C, β-carotene, flavonoids) on the antioxidant 
status, large-scale intervention trials showed that antioxidants per se do not protect against 
cancer. Still, it is evident that fruits and vegetables are protective against cancer, suggesting 
that other pathways (e.g. DNA repair) [50] may be influenced by phytochemicals, in addition 
to their action as antioxidants. Both cell culture experiments and human intervention trials 
have shown an influence of phytochemicals on DNA repair and it appears that effects on 
different repair pathways are variable. Roger Godschalk (University of Maastricht, The 
Netherlands) reported on ‘Biomarkers of DNA damage and repair in nutritional studies‘. In 
order to investigate the mechanism behind the procarcinogenic effect of β-carotene in 
smokers’ lung cancer, the effects of β-carotene and its metabolites vitamin A and retinoic acid 
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on neutrophil-induced genotoxicity were examined [51]. β-carotene metabolites enhanced 
inflammation-induced oxidative stress and genetic damage [51], and oxidative stress can 
reduce the DNA repair (i.e. nucleotide excision repair [NER]) capacity [52]. The effect of 
dietary intake of antioxidants on an individual’s NER capacity was measured in lymphocytes 
of individuals (n=168) before and after a 4-week dietary intervention of blueberry and apple 
juice [53]. On average the intervention did not affect NER capacity, but the effects may be 
modulated by genetic polymorphisms (e.g. XPA G23A) in NER-related genes. Karen Brown 
(University of Leicester, UK) delivered a talk on ‘Resveratrol: from glass to bedside‘. Clinical 
trials of tamoxifen and aspirin have provided proof that cancer prevention in humans is 
feasible [54]. Therefore, chemicals derived from the diet such as resveratrol found in red wine 
have been tested in healthy volunteers and in cancer patients in Leicester [55]. 
Comprehensive clinical trials assessing resveratrol pharmacokinetics have revealed that 
despite propensity for rapid metabolism, the parent compound predominates in colon tissue, 
supporting the colorectum as a target [56]. In contrast, resveratrol itself was not detectable in 
human prostate after a single dose, indicating efficacy in internal organs may be dependent on 
the potential contribution of metabolites. Results suggested a non-linear dose-response for the 
protective effect of resveratrol against colon cancer suggesting that lower doses of resveratrol 
may be more efficacious. These findings illustrate the need to integrate putative efficacy 
biomarkers early in the development process to identify optimal doses for clinical evaluation. 
 Roel Schins (IUF-Leibnitz Research Institute for Environmental Medicine, Germany) 
discussed ‘Particles, inflammation and oxidative DNA damage‘. Particle-induced ROS 
formation in lung epithelial cells is implicated in the activation of signalling pathways that 
drive pulmonary inflammation; marked increased in ROS formation may also cause oxidative 
damage to DNA [57]. For particle risk assessment it is important to discriminate between 
oxidative damage to DNA that results from ROS (i) generated in lung epithelial cells upon 
interaction with the particles or (ii) by activated phagocytes during lung inflammation. This is 
also important for newly engineered nanoparticles (ENPs) for which, besides the lung, the 
gastrointestinal tract represents the major target organ [58]. It was shown that several ENPs 
can cause oxidative damage to DNA in human Caco-2 intestinal epithelial cells [59]. 
Activated neutrophils also induced oxidative damage to DNA in Caco-2 cells focusing future 
studies on the interaction between ENPs and phagocytic cells during inflammation. Hanna 
Karlsson (Karolinska Institutet, Sweden) delivered a talk on ‘Nanoparticles and oxidative 
DNA damage – Trojan horses and assay interactions‘. By using the comet assay it was shown 
that copper oxide (CuO) nanoparticles were most potent in causing DNA damage and 
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oxidative lesions in DNA when comparing different metal oxide nanoparticles [60]. Higher 
toxictity as well as higher intracellular concentrations of copper were observed after exposure 
to the particles compared to the ions. Thus it seems that CuO nanoparticles act via a Trojan 
horse type mechanism, i.e. the particle structure increases cellular uptake and once inside the 
cell toxicity is likely caused by a combination of metal ions and a reactive surface of the CuO 
nanoparticles [61]. It was also noted that, when assessing DNA damage caused by 
nanoparticles using the comet assay, particles are often visible in the comet head which may 
lead to additional damage during the assay performance and/or interactions with the FPG 
enzymes used for the detection of oxidative damage to DNA [62]. Tanja Schwerdtle 
(University of Münster, Germany) reported on ‘Exposure relevant arsenic and manganese 
species strongly inhibit cellular oxidative DNA damage response pathways’. At exposure-
relevant concentrations the human carcinogen inorganic arsenic and its methylated 
metabolites are neither directly DNA reactive nor mutagenic. Therefore more likely 
epigenetic and indirect genotoxic effects, among others a modulation of DNA repair pathways 
[63,64], are important molecular mechanisms contributing to arsenic carcinogenicity. Thus in 
cultured human lung cells arsenic species affected base excision repair (BER) of oxidative 
damage to DNA by several mechanisms. Therefore after mixed arsenic exposure in humans, 
DNA repair most likely will be affected by different mechanisms. Regarding the mode of 
neurotoxic action of manganese new studies provide evidence that after overload manganese 
strongly disturbs the blood-brain barrier and the blood-cerebrospinal fluid (CSF) barrier and 
then might disturb DNA damage response in brain cells [65], which has been shown before to 
result in neurological diseases.  
 Bernd Epe (University of Mainz, Germany) discussed ‘Basal levels of oxidative DNA 
modifications in mice: origin, relevance and modulation’. A small increase of the basal level 
of oxidative DNA base modifications (i.e. less than one additional 8-oxodG per 106 base 
pairs) gives rise to a doubling of the spontaneous mutation rate and initiate carcinogenesis 
[66]. This was demonstrated in mice deficient in OGG1, the major repair glycosylase for 8-
oxodG. Oral dosing of mice with resveratrol significantly reduced the basal levels of 
endogenous oxidative DNA base modifications in the livers of both WT and repair-deficient 
animals [67]. The protection appears to be mediated by an up-regulation of several 
antioxidant response proteins (e.g. SOD1, SOD2, GPX1, HO1) which was observed in 
hepatocytes of resveratrol-treated animals. Oxidative stress not only increased the generation 
of oxidative damage to DNA, but also affected OGG1-mediated repair of the lesions. The 
human Ogg1-C326 variant appeared to be particularly sensitive to oxidative stress, resulting 
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in repair retardation and elevated genetic instability [68]. Eugenia Dogliotti (Istituto Superiore 
di Sanità, Italy) reported on ‘Genetic susceptibility to oxidative damage: from SNPs to 
function’. A genotype-phenotype correlation study was carried out in 225 healthy volunteers 
to identify OGG1 polymorphisms associated with impaired functional activity or altered gene 
expression. OGG1 activity was measured in protein extracts prepared from peripheral 
lymphocytes by using a fluorescence-based in vitro cleavage assay [69]. A significantly lower 
activity was detected in extracts from subjects homozygous for the C326 allele when 
compared with those homozygous for the S326 allele. A weakly significant inverse 
correlation was found between cleavage activity and gene expression but no association was 
found between OGG1 gene expression and the S326C polymorphism. The loss of enzymatic 
activity of the S326 polymorphic variant protein could be a consequence of conformational 
changes. These data confirm that the redox environment is a determinant of the repair 
efficiency of OGG1 and the susceptibility to oxidative stress of the S326C variant may 
account for its association with increased cancer risk. Ryszard Olinski (Nicolaus Copernicus 
University, Poland) discussed ‘Oxidatively damaged DNA in BRCA1 mutations carriers’ [70]. 
The study included healthy individuals, carriers of the BRCA1 mutation without symptoms of 
disease and patients with breast and ovarian cancer with BRCA1 mutations. BRCA1 mutation 
carriers had elevated levels of 8-oxodG in DNA of lymphocytes. In the distinct subpopulation 
of BRCA1 mutation carriers without symptoms of cancer who underwent adnexectomy, 
supplementation with selenium significantly decreased the level of 8-oxodG in comparison 
with the subgroup without supplementation [71]. Selenium supplementation probably leads to 
an increase in BER enzyme activitity (i.e. OGG1 activity) which in turn may result in the 
reduction of oxidative damage to DNA.   
 Helga Stopper delivered a talk on ‘Oxidative DNA damage during aging in a p47phox 
knock-out model’. NADPH oxidase is one enzyme mediating cellular production of ROS. 
Oxidative stress markers and genomic damage were evaluated in p47phox(−/−) mice, a 
knock-out model with a deletion of the p47phox subunit of NADH oxidase. Oxidative stress 
markers including 8-oxodG were significantly higher in urine of young (8-10 weeks) and old 
(52 weeks) WT mice than p47phox(−/−) mice. The levels of 8-oxodG from kidney DNA were 
also significantly different in WT and p47phox(−/−) mice in both young and old animals, with 
adduct levels increasing age-dependently. Treatment of isolated kidney cells with angiotensin 
II, shown to cause NADPH oxidase-mediated oxidative damage to DNA [72], resulted in 
significantly higher level of DNA damage in WT cells of both age groups, but no difference 
was found for cells isolated from p47phox(−/−) mice. Collectively, the p47phox subunit of 
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NADPH oxidase plays an important role in the formation of 8-oxodG. This represents a 
mechanism how NADPH oxidase is involved in the formation of ROS-mediated DNA 
damage which accumulates during aging.  
 Thanks to Mutagenesis and Oxford University Press three poster awards were given to 
young scientists: 1) Kathrin Gallé (University of Mainz, Germany) − ‘Overexpression of 
human Cu/Zn superoxide dismutase prevents the accumulation of oxidative DNA base 
damage in Ogg1-/-Csb-/- double knockout mice’; 2) Kristin Herrman (German Institute of 
Human Nutrition, Germany) − ‘Mass spectrometric detection and quantification of DNA 
adducts: usage for the identification of human and murine SULT forms involved in the 
activation of methyleugenol in vitro and in animal models’; and 3) Alicia Paini (Wageningen 
University, The Netherlands) − ‘The levels of estragole DNA adducts formed in vivo 
corresponds to the levels predicted by a physiologically based biodynamic (PBBD) model 
established in vitro’. All oral and poster abstracts of the workshop have been published online 
in Mutagenesis (include URL here).   
 
Acknowledgements 
The authors would like to thank the sponsors of the workshop for their generous financial 
support: United Kingdom Environmental Mutagen Society (UKEMS), Dutch Environmental 
Mutagen Society (Dutch EMS), German Environmental Mutagen Society (GUM), University 
of Münster, Germany, the German Research Foundation (DFG), Novartis Pharma AG (Basel, 
Switzlerland), Merck KGaA (Darmstadt, Germany), Biospace Lab (Paris, France), 
Boehringer-Ingelheim GmbH (Ingelheim, Germany), Oxford University Press (Oxford, UK), 
Perceptive Instruments (Haverhill, UK), Bio-Rad (Munich, Germany) and the US 
Environmental Mutagen Society (EMS). We thank Dr. Franziska Ebert and the Schwerdtle 
team for help with the local organisation of the workshop. The authors also wish to 
acknowledge the contribution made by participants to the preparation of this report through 
the provision of abstracts to the workshop. 
 14
References 
1. Wild, C.P. (2009) Environmental exposure measurement in cancer epidemiology. 
Mutagenesis, 24, 117-25. 
2. Wild, C.P. (2011) Future research perspectives on environment and health: the 
requirement for a more expansive concept of translational cancer research. Environ 
Health, 10 Suppl 1, S15. 
3. Arlt, V.M., Frei, E. and Schmeiser, H.H. (2007) ECNIS-sponsored workshop on 
biomarkers of exposure and cancer risk: DNA damage and DNA adduct detection and 
6th GUM-32P-postlabelling workshop, German Cancer Research Center, Heidelberg, 
Germany, 29-30 September 2006. Mutagenesis, 22, 83-8. 
4. Hecht, S.S., Yuan, J.M. and Hatsukami, D. (2010) Applying tobacco carcinogen and 
toxicant biomarkers in product regulation and cancer prevention. Chem Res Toxicol, 
23, 1001-8. 
5. Thomas, J.L., Guo, H., Carmella, S.G., Balbo, S., Han, S., Davis, A.B., Yoder, A.R., 
Murphy, S.E., An, L.C., Ahluwalia, J.S. and Hecht, S.S. (2011) Metabolites of a 
Tobacco-Specific Lung Carcinogen in Children Exposed to Secondhand or Thirdhand 
Tobacco Smoke in Their Homes. Cancer Epidemiol Biomarkers Prev. 
6. Yaun, J.M., Gao, Y.T., Carmella, S.G., Wang, R., Zhong, Y., Tao, L., Davis, A.B., 
Moy, K.A., Chen, M., Han, S., Yu, M.C. and Hecht, S.S. (2010) Urinary levels of 
polycyclic aromatic hydrocarbon metabolite in relation to lung cancer development in 
cigarette smokers of the Shanghai Cohort Study. In: Proceedings of the 101st Annual 
Meeting of the American Association for Cancer Research; 2010 Apr 17-21; 
Washington, DC. Philadelphia (PA) USA A863. 
7. Seidel, A., Spickenheuer, A., Straif, K., Rihs, H.P., Marczynski, B., Scherenberg, M., 
Dettbarn, G., Angerer, J., Wilhelm, M., Bruning, T., Jacob, J. and Pesch, B. (2008) 
New biomarkers of occupational exposure to polycyclic aromatic hydrocarbons. J 
Toxicol Environ Health A, 71, 734-45. 
8. Marczynski, B., Pesch, B., Wilhelm, M., Rossbach, B., Preuss, R., Hahn, J.U., 
Rabstein, S., Raulf-Heimsoth, M., Seidel, A., Rihs, H.P., Adams, A., Scherenberg, M., 
Erkes, A., Engelhardt, B., Straif, K., Kafferlein, H.U., Angerer, J. and Bruning, T. 
(2009) Occupational exposure to polycyclic aromatic hydrocarbons and DNA damage 
by industry: a nationwide study in Germany. Arch Toxicol, 83, 947-57. 
9. De Flora, S. and Izzotti, A. (2009) Modulation of genomic and postgenomic 
alterations in noncancer diseases and critical periods of life. Mutat Res, 667, 15-26. 
10. Balansky, R., Ganchev, G., Iltcheva, M., Steele, V.E. and De Flora, S. (2010) 
Prevention of cigarette smoke-induced lung tumors in mice by budesonide, phenethyl 
isothiocyanate, and N-acetylcysteine. Int J Cancer, 126, 1047-54. 
11. Balansky, R., Ganchev, G., Iltcheva, M., Nikolov, M., Steele, V.E. and De Flora, S. 
(2011) Differential carcinogenicity of cigarette smoke in mice exposed either 
transplacentally, early in life or in adulthood. Int J Cancer. 
12. John, K., Divi, R.L., Keshava, C., Orozco, C.C., Schockley, M.E., Richardson, D.L., 
Poirier, M.C., Nath, J. and Weston, A. (2010) CYP1A1 and CYP1B1 gene expression 
and DNA adduct formation in normal human mammary epithelial cells exposed to 
benzo[a]pyrene in the absence or presence of chlorophyllin. Cancer Lett, 292, 254-60. 
13. van Gijssel, H.E., Schild, L.J., Watt, D.L., Roth, M.J., Wang, G.Q., Dawsey, S.M., 
Albert, P.S., Qiao, Y.L., Taylor, P.R., Dong, Z.W. and Poirier, M.C. (2004) Polycyclic 
aromatic hydrocarbon-DNA adducts determined by semiquantitative 
immunohistochemistry in human esophageal biopsies taken in 1985. Mutat Res, 547, 
55-62. 
14. Arlt, V.M., Stiborova, M., Henderson, C.J., Thiemann, M., Frei, E., Aimova, D., 
Singh, R., Gamboa da Costa, G., Schmitz, O.J., Farmer, P.B., Wolf, C.R. and Phillips, 
 15
D.H. (2008) Metabolic activation of benzo[a]pyrene in vitro by hepatic cytochrome 
P450 contrasts with detoxification in vivo: experiments with hepatic cytochrome P450 
reductase null mice. Carcinogenesis, 29, 656-65. 
15. Hockley, S.L., Arlt, V.M., Jahnke, G., Hartwig, A., Giddings, I. and Phillips, D.H. 
(2008) Identification through microarray gene expression analysis of cellular 
responses to benzo(a)pyrene and its diol-epoxide that are dependent or independent of 
p53. Carcinogenesis, 29, 202-10. 
16. Van Berkel, J.J., Dallinga, J.W., Moller, G.M., Godschalk, R.W., Moonen, E.J., 
Wouters, E.F. and Van Schooten, F.J. (2010) A profile of volatile organic compounds 
in breath discriminates COPD patients from controls. Respir Med, 104, 557-63. 
17. Schults, M.A., Timmermans, L., Godschalk, R.W., Theys, J., Wouters, B.G., van 
Schooten, F.J. and Chiu, R.K. (2010) Diminished carcinogen detoxification is a novel 
mechanism for hypoxia-inducible factor 1-mediated genetic instability. J Biol Chem, 
285, 14558-64. 
18. Decordier, I., Papine, A., Plas, G., Roesems, S., Vande Loock, K., Moreno-Palomo, J., 
Cemeli, E., Anderson, D., Fucic, A., Marcos, R., Soussaline, F. and Kirsch-Volders, 
M. (2009) Automated image analysis of cytokinesis-blocked micronuclei: an adapted 
protocol and a validated scoring procedure for biomonitoring. Mutagenesis, 24, 85-93. 
19. Decordier, I., De Bont, K., De Bock, K., Mateuca, R., Roelants, M., Ciardelli, R., 
Haumont, D., Knudsen, L.E. and Kirsch-Volders, M. (2007) Genetic susceptibility of 
newborn daughters to oxidative stress. Toxicol Lett, 172, 68-84. 
20. Decordier, I., Loock, K.V. and Kirsch-Volders, M. (2010) Phenotyping for DNA 
repair capacity. Mutat Res, 705, 107-29. 
21. Speit, G., Zeller, J. and Neuss, S. (2011) The in vivo or ex vivo origin of micronuclei 
measured in human biomonitoring studies. Mutagenesis, 26, 107-10. 
22. Georgiadis, P., Kaila, S., Makedonopoulou, P., Fthenou, E., Chatzi, L., Pletsa, V. and 
Kyrtopoulos, S.A. (2011) Development and validation of a new, sensitive 
immunochemical assay for O-methylguanine in DNA and its application in a 
population study. Cancer Epidemiol Biomarkers Prev, 20, 82-90. 
23. Merlo, D.F., Wild, C.P., Kogevinas, M., Kyrtopoulos, S. and Kleinjans, J. (2009) 
NewGeneris: a European study on maternal diet during pregnancy and child health. 
Cancer Epidemiol Biomarkers Prev, 18, 5-10. 
24. Funk, D., Sorg, B.L., Lindner, S.C. and Schmeiser, H.H. (2010) 32P-postlabeling 
analysis of DNA adducts formed by leukotriene A4 (LTA4). Environ Mol Mutagen, 
51, 338-43. 
25. Topinka, J., Rossner, P., Jr., Milcova, A., Schmuczerova, J., Svecova, V. and Sram, 
R.J. (2011) DNA adducts and oxidative DNA damage induced by organic extracts 
from PM2.5 in an acellular assay. Toxicol Lett, 202, 186-92. 
26. Dracinsky, M., Cvacka, J., Semanska, M., Martinek, V., Frei, E. and Stiborova, M. 
(2009) Mechanism of formation of (deoxy)guanosine adducts derived from 
peroxidase-catalyzed oxidation of the carcinogenic nonaminoazo dye 1-phenylazo-2-
hydroxynaphthalene (Sudan I). Chem Res Toxicol, 22, 1765-73. 
27. Naiman, K., Dracinska, H., Martinkova, M., Sulc, M., Dracinsky, M., Kejikova, L., 
Hodek, P., Hudecek, J., Liberda, J., Schmeiser, H.H., Frei, E. and Stiborova, M. 
(2008) Redox cycling in the metabolism of the environmental pollutant and suspected 
human carcinogen o-anisidine by rat and rabbit hepatic microsomes. Chem Res 
Toxicol, 21, 1610-21. 
28. Mizerovska, J., Dracinska, H., Frei, E., Schmeiser, H.H., Arlt, V.M. and Stiborova, M. 
(2011) Induction of biotransformation enzymes by the carcinogenic air-pollutant 3-
nitrobenzanthrone in liver, kidney and lung, after intra-tracheal instillation in rats. 
Mutat Res, 720, 34-41. 
 16
29. Stiborova, M., Martinek, V., Svobodova, M., Sistkova, J., Dvorak, Z., Ulrichova, J., 
Simanek, V., Frei, E., Schmeiser, H.H., Phillips, D.H. and Arlt, V.M. (2010) 
Mechanisms of the different DNA adduct forming potentials of the urban air 
pollutants 2-nitrobenzanthrone and carcinogenic 3-nitrobenzanthrone. Chem Res 
Toxicol, 23, 1192-201. 
30. Schmeiser, H.H., Stiborova, M. and Arlt, V.M. (2009) Chemical and molecular basis 
of the carcinogenicity of Aristolochia plants. Curr Opin Drug Discov Devel, 12, 141-8. 
31. Kucab, J.E., Phillips, D.H. and Arlt, V.M. (2010) Linking environmental carcinogen 
exposure to TP53 mutations in human tumours using the human TP53 knock-in 
(Hupki) mouse model. Febs J, 277, 2567-83. 
32. Levova, K., Moserova, M., Kotrbova, V., Sulc, M., Henderson, C.J., Wolf, C.R., 
Phillips, D.H., Frei, E., Schmeiser, H.H., Mares, J., Arlt, V.M. and Stiborova, M. 
(2011) Role of Cytochromes P450 1A1/2 in Detoxication and Activation of 
Carcinogenic Aristolochic Acid I: Studies with the Hepatic NADPH:Cytochrome 
P450 Reductase Null (HRN) Mouse Model. Toxicol Sci, 121, 43-56. 
33. Doerge, D.R., da Costa, G.G., McDaniel, L.P., Churchwell, M.I., Twaddle, N.C. and 
Beland, F.A. (2005) DNA adducts derived from administration of acrylamide and 
glycidamide to mice and rats. Mutat Res, 580, 131-41. 
34. Von Tungeln, L.S., Churchwell, M.I., Doerge, D.R., Shaddock, J.G., McGarrity, L.J., 
Heflich, R.H., da Costa, G.G., Marques, M.M. and Beland, F.A. (2009) DNA adduct 
formation and induction of micronuclei and mutations in B6C3F1/Tk mice treated 
neonatally with acrylamide or glycidamide. Int J Cancer, 124, 2006-15. 
35. Baasanjav-Gerber, C., Hollnagel, H.M., Brauchmann, J., Iori, R. and Glatt, H. (2010) 
Detection of genotoxicants in Brassicales using endogenous DNA as a surrogate target 
and adducts determined by 32P-postlabelling as an experimental end point. 
Mutagenesis. 
36. Baasanjav-Gerber, C., Hollnagel, H.M., Brauchmann, J., Iori, R. and Glatt, H. (2011) 
Detection of genotoxicants in Brassicales using endogenous DNA as a surrogate target 
and adducts determined by 32P-postlabelling as an experimental end point. 
Mutagenesis, 26, 407-13. 
37. Lan, Q., Zhang, L., Li, G., Vermeulen, R., Weinberg, R.S., Dosemeci, M., Rappaport, 
S.M., Shen, M., Alter, B.P., Wu, Y., Kopp, W., Waidyanatha, S., Rabkin, C., Guo, W., 
Chanock, S., Hayes, R.B., Linet, M., Kim, S., Yin, S., Rothman, N. and Smith, M.T. 
(2004) Hematotoxicity in workers exposed to low levels of benzene. Science, 306, 
1774-6. 
38. Vlaanderen, J., Lan, Q., Kromhout, H., Rothman, N. and Vermeulen, R. (2011) 
Occupational benzene exposure and the risk of lymphoma subtypes: a meta-analysis of 
cohort studies incorporating three study quality dimensions. Environ Health Perspect, 
119, 159-67. 
39. Baan, R., Grosse, Y., Straif, K., Secretan, B., El Ghissassi, F., Bouvard, V., 
Benbrahim-Tallaa, L., Guha, N., Freeman, C., Galichet, L. and Cogliano, V. (2009) A 
review of human carcinogens--Part F: chemical agents and related occupations. Lancet 
Oncol, 10, 1143-4. 
40. Raaschou-Nielsen, O., Bak, H., Sorensen, M., Jensen, S.S., Ketzel, M., Hvidberg, M., 
Schnohr, P., Tjonneland, A., Overvad, K. and Loft, S. (2010) Air pollution from traffic 
and risk for lung cancer in three Danish cohorts. Cancer Epidemiol Biomarkers Prev, 
19, 1284-91. 
41. Londahl, J., Massling, A., Swietlicki, E., Brauner, E.V., Ketzel, M., Pagels, J. and Loft, 
S. (2009) Experimentally determined human respiratory tract deposition of airborne 
particles at a busy street. Environ Sci Technol, 43, 4659-64. 
 17
42. Moller, P. and Loft, S. (2010) Oxidative damage to DNA and lipids as biomarkers of 
exposure to air pollution. Environ Health Perspect, 118, 1126-36. 
43. Singh, R., Kaur, B., Kalina, I., Popov, T.A., Georgieva, T., Garte, S., Binkova, B., 
Sram, R.J., Taioli, E. and Farmer, P.B. (2007) Effects of environmental air pollution 
on endogenous oxidative DNA damage in humans. Mutat Res, 620, 71-82. 
44. Singh, R., Sram, R.J., Binkova, B., Kalina, I., Popov, T.A., Georgieva, T., Garte, S., 
Taioli, E. and Farmer, P.B. (2007) The relationship between biomarkers of oxidative 
DNA damage, polycyclic aromatic hydrocarbon DNA adducts, antioxidant status and 
genetic susceptibility following exposure to environmental air pollution in humans. 
Mutat Res, 620, 83-92. 
45. Marsden, D.A., Jones, D.J., Britton, R.G., Ognibene, T., Ubick, E., Johnson, G.E., 
Farmer, P.B. and Brown, K. (2009) Dose-response relationships for N7-(2-
hydroxyethyl)guanine induced by low-dose [14C]ethylene oxide: evidence for a novel 
mechanism of endogenous adduct formation. Cancer Res, 69, 3052-9. 
46. Evans, M.D., Saparbaev, M. and Cooke, M.S. (2010) DNA repair and the origins of 
urinary oxidized 2'-deoxyribonucleosides. Mutagenesis, 25, 433-42. 
47. Evans, M.D., Singh, R., Mistry, V., Sandhu, K., Farmer, P.B. and Cooke, M.S. (2008) 
Analysis of urinary 8-oxo-7,8-dihydro-purine-2'-deoxyribonucleosides by LC-MS/MS 
and improved ELISA. Free Radic Res, 42, 831-40. 
48. Evans, M.D., Olinski, R., Loft, S. and Cooke, M.S. (2010) Toward consensus in the 
analysis of urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine as a noninvasive biomarker 
of oxidative stress. FASEB J, 24, 1249-60. 
49. Collins, A.R. and Azqueta, A. (2011) DNA repair as a biomarker in human 
biomonitoring studies; further applications of the comet assay. Mutat Res. 
50. Ramos, A.A., Pereira-Wilson, C. and Collins, A.R. (2010) Protective effects of ursolic 
acid and luteolin against oxidative DNA damage include enhancement of DNA repair 
in Caco-2 cells. Mutat Res, 692, 6-11. 
51. van Helden, Y.G., Keijer, J., Knaapen, A.M., Heil, S.G., Briede, J.J., van Schooten, 
F.J. and Godschalk, R.W. (2009) Beta-carotene metabolites enhance inflammation-
induced oxidative DNA damage in lung epithelial cells. Free Radic Biol Med, 46, 299-
304. 
52. Gungor, N., Godschalk, R.W., Pachen, D.M., Van Schooten, F.J. and Knaapen, A.M. 
(2007) Activated neutrophils inhibit nucleotide excision repair in human pulmonary 
epithelial cells: role of myeloperoxidase. FASEB J, 21, 2359-67. 
53. Langie, S.A., Wilms, L.C., Hamalainen, S., Kleinjans, J.C., Godschalk, R.W. and van 
Schooten, F.J. (2010) Modulation of nucleotide excision repair in human lymphocytes 
by genetic and dietary factors. Br J Nutr, 103, 490-501. 
54. Patel, K.R., Scott, E., Brown, V.A., Gescher, A.J., Steward, W.P. and Brown, K. 
(2011) Clinical trials of resveratrol. Ann N Y Acad Sci, 1215, 161-9. 
55. Brown, V.A., Patel, K.R., Viskaduraki, M., Crowell, J.A., Perloff, M., Booth, T.D., 
Vasilinin, G., Sen, A., Schinas, A.M., Piccirilli, G., Brown, K., Steward, W.P., 
Gescher, A.J. and Brenner, D.E. (2010) Repeat dose study of the cancer 
chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, 
and effect on the insulin-like growth factor axis. Cancer Res, 70, 9003-11. 
56. Patel, K.R., Brown, V.A., Jones, D.J., Britton, R.G., Hemingway, D., Miller, A.S., 
West, K.P., Booth, T.D., Perloff, M., Crowell, J.A., Brenner, D.E., Steward, W.P., 
Gescher, A.J. and Brown, K. (2010) Clinical pharmacology of resveratrol and its 
metabolites in colorectal cancer patients. Cancer Res, 70, 7392-9. 
57. Schins, R.P. and Knaapen, A.M. (2007) Genotoxicity of poorly soluble particles. Inhal 
Toxicol, 19 Suppl 1, 189-98. 
 18
58. Donaldson, K., Poland, C.A. and Schins, R.P. (2010) Possible genotoxic mechanisms 
of nanoparticles: criteria for improved test strategies. Nanotoxicology, 4, 414-20. 
59. Gerloff, K., Albrecht, C., Boots, A.W., Foerster, I. and Schins, R.P.F. (2009) 
Cytotoxicity and oxidative DNA damage by nanoparticles in human intestinal Caco-2 
cells. Nanotoxicology, 3, 355-364. 
60. Karlsson, H.L., Cronholm, P., Gustafsson, J. and Moller, L. (2008) Copper oxide 
nanoparticles are highly toxic: a comparison between metal oxide nanoparticles and 
carbon nanotubes. Chem Res Toxicol, 21, 1726-32. 
61. Karlsson, H.L., Holgersson, A. and Moller, L. (2008) Mechanisms related to the 
genotoxicity of particles in the subway and from other sources. Chem Res Toxicol, 21, 
726-31. 
62. Karlsson, H.L. (2010) The comet assay in nanotoxicology research. Anal Bioanal 
Chem, 398, 651-66. 
63. Hartwig, A. and Schwerdtle, T. (2009) Arsenic induced carcinogenicity: new insights 
in molecular mechanisms. In Hadjiliadis, N. and Sletten, E. (eds.), Metal-Complex 
DNA Interactions. John Wiley &Sons, pp. 491-582. 
64. Nollen, M., Ebert, F., Moser, J., Mullenders, L.H., Hartwig, A. and Schwerdtle, T. 
(2009) Impact of arsenic on nucleotide excision repair: XPC function, protein level, 
and gene expression. Mol Nutr Food Res, 53, 572-82. 
65. Bornhorst, J., Ebert, F., Hartwig, A., Michalke, B. and Schwerdtle, T. (2010) 
Manganese inhibits poly(ADP-ribosyl)ation in human cells: a possible mechanism 
behind manganese-induced toxicity? J Environ Monit, 12, 2062-9. 
66. Trapp, C., Reite, K., Klungland, A. and Epe, B. (2007) Deficiency of the Cockayne 
syndrome B (CSB) gene aggravates the genomic instability caused by endogenous 
oxidative DNA base damage in mice. Oncogene, 26, 4044-8. 
67. Fusser, M., Nesse, G.J., Khobta, A., Xia, N., Li, H., Klungland, A. and Epe, B. (2011) 
Spontaneous mutagenesis in Csb(m/m)Ogg1(/) mice is attenuated by dietary 
resveratrol. Carcinogenesis, 32, 80-5. 
68. Bravard, A., Vacher, M., Moritz, E., Vaslin, L., Hall, J., Epe, B. and Radicella, J.P. 
(2009) Oxidation status of human OGG1-S326C polymorphic variant determines 
cellular DNA repair capacity. Cancer Res, 69, 3642-9. 
69. Mazzei, F., Guarrera, S., Allione, A., Simonelli, V., Narciso, L., Barone, F., Minoprio, 
A., Ricceri, F., Funaro, A., D'Errico, M., Vogel, U., Matullo, G. and Dogliotti, E. 
(2011) 8-Oxoguanine DNA-glycosylase repair activity and expression: a comparison 
between cryopreserved isolated lymphocytes and EBV-derived lymphoblastoid cell 
lines. Mutat Res, 718, 62-7. 
70. Dziaman, T., Huzarski, T., Gackowski, D., Rozalski, R., Siomek, A., Szpila, A., Guz, 
J., Lubinski, J. and Olinski, R. (2009) Elevated level of 8-oxo-7,8-dihydro-2'-
deoxyguanosine in leukocytes of BRCA1 mutation carriers compared to healthy 
controls. Int J Cancer, 125, 2209-13. 
71. Dziaman, T., Huzarski, T., Gackowski, D., Rozalski, R., Siomek, A., Szpila, A., Guz, 
J., Lubinski, J., Wasowicz, W., Roszkowski, K. and Olinski, R. (2009) Selenium 
supplementation reduced oxidative DNA damage in adnexectomized BRCA1 
mutations carriers. Cancer Epidemiol Biomarkers Prev, 18, 2923-8. 
72. Schmid, U., Stopper, H., Schweda, F., Queisser, N. and Schupp, N. (2008) 
Angiotensin II induces DNA damage in the kidney. Cancer Res, 68, 9239-46. 
 
 
 
 
 
